In normal subjects the later part of the cone a-wave to a brief flash increases in amplitude after 50-100 ms darkness due to a contribution from secondary hyperpolarising cells. We recorded these responses along with clinical ON and OFF ERGs in patients with inner retinal dysfunction to see if this part of the a-wave is affected. Patients with autoimmune-like retinopathy and CSNB2 had abnormal ON and OFF responses but the a-wave increased in amplitude in the dark as in normals. Conversely, the OFF-response was normal in CSNB1 but the a-wave did not increase in the dark. Contrary to expectation these results show some hyperpolarising cell function in autoimmune-like disease and CSNB2 and some OFF-pathway abnormality in CSNB1. The a-and d-wave are needed to assess OFF-pathway function.
Introduction
Several studies in non-human primate and normal human volunteers have established that post receptoral cells make a significant contribution to the later part of the light adapted a-wave of the cone-driven ERG (Bush & Sieving, 1994; Friedburg, Allen, Mason, & Lamb, 2004; Hood & Birch, 1993 Robson, Saszik, Ahmed, & Frishman, 2003; Paupoo, Mahroo, Friedburg, & Lamb, 2000) . In non-human primates intra-vitreal application of pharmacological agents that block activity of inner retinal neurones suggest that the responses of hyperpolarising bipolar cells (HBCs) may summate with the later part of the cone photoreceptor component of the ERG a-wave but a contribution from horizontal cells (HCs) cannot be excluded (Bush & Sieving, 1994; Robson et al., 2003) . The contribution of these post-receptoral mechanisms cannot be identified clearly in light adapted human ERG a-waves recorded under standard ERG procedures such as those recommended for clinical ERG studies (Marmor et al., 2009 ). However, a post-receptoral contribution to the cone-driven a-wave can be identified in the normal human ERG response to high energy stimuli, especially when presented against a bright background (Friedburg, Thomas, & Lamb, 2001; Hood & Birch, 1993; Paupoo et al., 2000) . Further studies in both human subjects and in non-human primate showed that this post-receptoral component can also be revealed more clearly in the response to low as well as high energy stimuli if the stimulus is delivered after briefly suppressing a rod-saturating background light (Bradshaw, 2007; Robson et al., 2003) . Parametric studies showed that the cone a-wave increased in amplitude after a brief period of darkness, reaching a maximum after a 75-100 ms dark period and the increase was proportionately greater at later times of the a-wave (typically at times later than 8 ms). It was suggested that the increase in amplitude was due to the contribution of secondary hyperpolarising cells that were suppressed by relatively weak background adapting lights and which recovered their sensitivity very rapidly in the dark.
If, as suggested, secondary hyperpolarising neurones contribute significantly to the later part of the cone a-wave it should be possible to obtain specific evidence for this in patients with disease that is thought to specifically affect only depolarising bipolar cells (DBCs), or diseases that affect both DBCs and secondary hyperpolarising neurones. In all forms of Congenital Stationary Night Blindnes (CSNB) the b-wave of the dark adapted ERG is severely reduced in amplitude and inner retinal components of the light adapted ERG (b-wave, OPs and PhNR) may also be altered, but the photoreceptor-generated a-wave tends to be normal or nearnormal in amplitude (Allen et al., 2003; Bradshaw et al., 2004; Miyake, Yagasaki, Horiguchi, Kawase, & Kanda, 1986; Miyake, Horiguchi, Ota, & Shiroyama, 1987a; Sustar, Stirn-Kranjc, Hawlina, & Brecelj, 2008; Tremblay, Laroch, & Becker, 1995) . In one form of the disease (CSNB1) abnormality appears to be confined to 0042-6989/$ -see front matter Ó 2010 Elsevier Ltd. All rights reserved. doi:10.1016/j.visres.2010.08.028 ON-pathway function because rod and cone b-waves are abnormal but the OFF response to a long flash is normal or even increased in amplitude; in the other form of the disease (CSNB2) the OFF (dwave) and the ON b-waves are abnormal, indicating abnormality of HBCs as well as DBCs (Langrova et al., 2002; Miyake, Yagasaki, Horiguchi, & Kawase, 1987b; Sieving, 1993; Tremblay et al., 1995) .
The contribution of secondary hyperpolarising neurones to the cone a-wave can also be investigated in another group of patients with ERG responses resembling those of patients with CSNB but who have an acquired form of night blindness caused by autoimmune-related mechanisms. These retinopathies encompass the better studied paraneoplastic syndromes such as cancer-associated (CAR) and melanoma-associated (MAR) retinopathy (Alexander, Fishman, Peachey, Marchese, & Tso, 1992; Berson & Lessell, 1988; Milam et al., 1993; Singh, Milam, Shields, Potter, & Shields, 1995) as well as a larger group of patients with similar symptoms but without evidence of malignancy (Fishman, Alexander, Milam, & Derlacki, 1996; Mizener et al., 1997; Peek, Verbraak, Coevoet, & Kijlstra, 1998) ; for recent reviews see Audo, Robson, Holder, and Moore (2008) Heckenlively, Aptsiauri, and Holder (2006) . Patients frequently present with recent, painless onset of night blindness, abnormality of visual fields, photopsia and sometimes blurring of central vision with minimal retinal changes. Symptoms are often unilateral but the second eye may become involved at a later time. ERGs are usually severely abnormal in the affected eye and the changes are more often confined to inner retinal responses. Serum taken from patients with MAR typically show evidence of antibodies against retinal cells and/or staining of inner retinal cells (Alexander et al., 1992; Rush, 1993; Milam et al., 1993; Mizener et al., 1997; Peek et al., 1998; Singh et al., 1995) which support the clinical diagnosis and indicate that the clinical and ERG changes are caused by a autoimmune mechanism. The antibodies are thought to specifically affect DBCs because the ERG ON-pathway b-wave is abnormal but the OFF-pathway d-wave is normal (Alexander et al., 1992; Fishman et al., 1996; Lei, Bush, Milam, & Sieving, 2000) . However, many patients without malignancy who fit the clinical picture have mixtures of antibodies directed against either other unidentified retinal antigens or ones whose pathogenicity is unknown (Fishman et al., 1996; Heckenlively et al., 2006; Mizener et al., 1997; Peek et al., 1998) . Moreover, an appreciable number of healthy control subjects can manifest antiretinal antibodies (Shimazaki, Jirawuthiworavong, Heckenlively, & Gordon, 2008) . Therefore, there is no definitive laboratory test and the diagnosis of non-paraneoplastic retinopathy is made on the basis of the typical cohort of presenting symptoms summarised above, normal eye examination and severely abnormal ERGs indicating inner retinal abnormality (Ferreyra et al., 2009; Heckenlively, Ferreyra, & Janasundera, 2010; Jampol & Fishman, 2009) .
We report ERG findings in two patients with unilateral symptoms and ERG changes suggesting autoimmune-like retinopathy and in three patients with a diagnosis of CSNB, two having ERG responses typical of CSNB1 and the other of CSNB2. Standard ISCEV clinical ERGs were recorded to confirm that abnormality was confined to inner retina in all five patients. We also recorded ERG responses to a red stimulus flash presented at various times after briefly extinguishing a rod-suppressing blue background light, as described previously (Bradshaw, 2007) , in order to investigate the post-receptoral contribution to the cone a-wave. If secondary hyperpolarising neurones make a significant contribution to the post-receptoral part of the cone a-wave, patients with CSNB1, and possibly also those with autoimmune-like retinopathy, should show a normal increase in a-wave amplitude when the stimulus is presented after 50-100 ms of darkness. Conversly, patients with CSNB2 should show minimal or no change in a-wave amplitude under these test conditions. Surprisingly, the results were opposite to expectation.
Methods

ERG procedures
Full details of stimulation and recording procedures have been given elsewhere (Bradshaw et al., 2004; Bradshaw, 2007) and are repeated here in summary form.
Clinical ERGs
The stimulus was a Xenon flash delivered via a integrating sphere (Ganzfeld) to provide full field illumination of the eyes. The ERG procedure incorporated rod and cone ERG responses recommended by the International Society for Clinical Electrophysiology of Vision (Marmor et al., 2009) . After pupil dilation the eyes were dark adpated for 20 min and rod and mixed rod-cone (maximal) responses were recorded to a dim and bright flash respectively. The eyes were then exposed continuously to a rod-suppressing white light (25 ph.cd.s.m 2 for 10 min after which cone ERGs were recorded to a bright flash, 30 Hz flicker and a long-flash (200 ms) stimulus.
Red flash on blue background
Adapting and stimulus lights were delivered in a second custom-built Ganzfeld. The blue background light (Kodak Wratten 47B) from a tungsten halogen lamp was 39 sc.cd.m 2 and passed through an electronically operated shutter before entry into the Ganzfeld. The stimulus was a 0.86 ph.cd.s.m 2 red flash (duration 44 uS) which is sufficient to nearly saturate all ERG components except the a-wave. Responses were recorded initially to a red flash presented against a steady background and then to the same stimulus presented 0-300 ms after brief (100-300 ms) suppression of the background field. The subject's eyes were exposed continuously to the rod-suppressing background between experimental conditions.
ERG data acquisition
ERGs were recorded from one eye by means of a DTL electrode located in the lower conjunctival fornix. The reference electrode was on the ipsilateral outer canthus and the ground electrode on the forehead. The eye was anaesthetised with Benoxinate 1% and the pupil dilated with Tropicamide 1%. The pupil diameter was between 8 and 8.5 mm for each subject. ERG data was acquired using custom software running on a laboratory PC. The signals were differentially amplified with a gain of 1000 over a bandwidth of 1-1000 Hz and digitized at a sample rate of 2 kHz with a resolution of 12 bits. The sweep time was 200 ms for clinical ERGs and 100 ms for the red flash ERG responses. Eight to 16 responses were averaged for each trial depending on signal quality and a pre-set voltage window allowed automatic rejection of sweeps contaminated by artefact. At least two averaged responses were acquired for each test condition and these were stored for off-line averaging and measurement. The electronic shutters and flash guns of the Ganzfelds were also controlled by commands from the data aquisition computer.
Measurement of ERG responses
The a-wave, rod-specific b-wave and d-wave were measured from baseline to peak. The mixed rod-cone and the cone-specific b-wave was easy to identify in normals and was measured from the trough of the a-wave. The cone b-wave was measured in the same way in patients but the rod-cone b-wave was abnormal and it was difficult to make reliable measurements because there was no single, clearly defined peak; amplitude was measured from the trough of the a-wave to the maximum amplitude within the time period 45-75 ms, which covers the range of peak latenies for normal subjects.
Subjects
Normal
Clinical ERGs were compared with those of 26 normal volunteers. ERG responses to the red flash procedures were compared with those of eight normal volunteers. Informed consent was obtained from each subject following detailed explanation of the purpose and nature of the ERG procedure.
Patients
All the patients had been referred routinely for electrodiagnostic studies as an aid to establishing an accurate clinical diagnosis.
P1. Presented first at age 51 yrs with deteriorating vision. Colour vision, VA visual fields and eye examination were normal. There was no relative afferent pupil defect and no family history of eye disease. Red colours appeared desaturated in the left eye and he was referred with a possible diagnosis of optic neuritis. VEP responses were normal and he was re-referred for ERG testing which showed very abnormal rod and cone inner retinal responses for the left eye affecting both ON-and OFF-pathways. On further questioning he reported that his vision with the left eye had been poor but unchanged for about 30 yrs. Colours seen with the left eye were relatively desaturated and in bright light objects lacked sharp definition; he described the visual experience as like a white-out or overexposed of the visual scene. He was photophobic in the left eye and often used sun glasses. Vision was also poorer with the left eye compared with the right eye in dim ligh. He was re-tested annually for the following 4 yrs and there was no change in symptoms or in ERG responses. Melanoma was positively excluded during this period.
P2 Presented first at age 52 yrs complaining that for 6-9 months vision with the left eye was poor in low light and there was a blind area in the upper left temporal quadrant. The visual field of the left eye was constricted on automated perimetry but the eye examination was essentially normal. He was referred with suspected subtle retinal dystrophy and the ERG responses confirmed unilateral reduction of inner retinal responses affecting both rod and cone pathways. On detailed questioning he reported that the onset of symptoms was co-incident with a viral infection. Subjectively, his central vision in the left eye was normal but he experienced decreased awareness of objects in peripheral vision. In dim light he could not see objects clearly and in the dark he could see very little or nothing with the left eye. In bright sunlight he, like P1, described his vision with the left eye as like a over-exposure of the visual scene -everything looked much brighter than with the right eye and objects were indistinct. He was re-tested at variable intervals for a period of 8 yrs during which time there was slight deterioration of ERG responses and subjective vision for the symptomatic eye. The left disc became pale but there was no other fundus abnormality. Malignancy was positively excluded.
Both patients had unilateral acquired disease and the cohort of symptoms combined with severely abnormal unilateral inner retinal abnormality were consistent with reported cases of autoimmune-related disease and this was the presumptive diagnosis when they were discharged from routine follow-up. In the absence of a definitive laboratory test we will refer to these patients as having autoimmune-like disease. For brevity, especially in labelling Figures, we use the abbreviation AI; this is distinct from the abbreviation AIR more commonly used in investigations of patients with confirmed autoimmune disease such as MAR.
P3. This was a 58 yr old man who presented with deteriorating vision in the left eye. On examination he was found to be a moderately strong myope with a cataract in the left eye and a history suggesting amblyopia of the right eye. His discs, maculae, peripheral retina and colour vision were normal but acuity was reduced to 6/60 right and 6/18 left. There was no known family history of relevant eye disease. On questioning he reported that he had always had poor vision in the dark but this had been non-progressive and had never been investigated. He was referred for ERG testing which showed normal rod and cone a-waves, very reduced amplitude b-waves, absence of OPs and an electro-negative waveform to a bright flash.
P4. This male patient presented first age 24 yrs with nystagmus, left amblyopia and a history of night blindness. His brother also had poor vision in the dark and both showed normal rod and cone ERG a-waves, severely reduced amplitude b-waves, absent dark adapted OPs and an electro-negative waveform to a bright stimulus flash. The eye examination was normal. On re-testing 9 yrs later, at the time of this study, there had been no deterioration in either his symptoms or ERG responses.
A diagnosis of XLCSNB was made in both cases and the ERG responses suggested CSNB1-type disease (see Results).
P5. This male patient first presented age 26 yrs with an essentially normal eye examination, intermittent nystagmus and moderately strong myopia. He was tested along with his maternal grandfather and both showed normal rod and cone ERG a-waves but sub-normal b-waves. The dark adapted OPs were normal amplitude but cone OPs were absent. The ERG response to 30 Hz flicker was abnormally low amplitude and had a double peaked waveform. He was re-tested age 41 yrs at the time of this study and ERG responses were unchanged. This combination of ERG features suggested XLCSNB2-type disease (see results). Fig. 1 shows the clinical ERG response waveforms for a typical normal volunteer (left panel) and for each patient. Fig. 2 shows plots of response amplitude for each normal volunteer and for each patient.
Results
Clinical ERGs
All rod and cone inner retinal ERG responses (b-wave, OPs, 30 Hz and PhNR) were severely abnormal in the symptomatic eye of patients P1 and P2 with AI disease; these responses were normal in the asymptomatic eye. Rod a-waves to bright flashes were normal in both patients. The cone a-wave was altered in both patients but peak amplitude was normal in one and only marginally reduced in the other patient compared with responses of normal subjects. These responses were typical of ERGs in patients with inner retinal disease. The long-flash ERG d-wave was also abnormal in both patients indicating OFF as well as ON-pathway abnormality.
The rod-specific b-wave and bright flash b-wave were severely reduced in amplitude and the OPs were absent in the ERG responses of patients P3 and P4. The rod a-wave was normal in one and only marginally reduced in the other patient so that the response to a bright flash had a negative-waveform. Cone a-and b-wave amplitudes were normal but the form of the response was altered because of the absence of one or more OPs. The cone PhNR was also severely reduced in amplitude but the 30 Hz response and the long-flash cone d-wave was normal in both patients. These results confirm normal photoreceptor responses but abnormal inner retinal function confined to the ON-pathway and are typical of reported findings in CSNB1.
Rod and cone a-wave amplitudes were normal in patient P5. Rod b-waves to dim and bright flashes were very reduced in amplitude but responses were not as severely affected as those of patients P3 and P4 and the dark adapted OPs were preserved. The cone b-wave amplitude was at the lower limit of the range of values for normal subjects but the light adapted OPs and the PhNR were not identifiable. The 30 Hz flicker response was severely reduced in amplitude and had a double-peaked waveform. The ERG to a long-flash stimulus was compromised by the patients photophobia and the response was technically too poor to yield specific information about OFF-pathway function. However, all ERG responses to short flash stimuli were typical of reported finding in CSNB2 and the patients photophobia was also consistent with this form of the disease. Fig. 3 shows the ERG responses to a brief red flash. The top row shows the full waveform of the ERG response recorded against a steady background. The lower four traces plotted with a solid line is the same a-wave replicated down the page and on an expanded time scale. A previous study of these responses in normal subjects showed that the most significant changes in a-wave amplitude and waveform occur when the stimulus is presented 0-100 ms after briefly extinguishing a rod-suppressing background (Bradshaw, 2007) . The broken-line traces show the responses recorded when the stimulus was presented 25, 50, 75 and 100 ms after extinguishing the background (top to bottom on expanded x-axis plots).
ERG responses to a red flash stimulus
Both AI patients show very reduced b-wave amplitude and an absence of OPs, PhNR and i-wave; the a-wave was also reduced in amplitude compared with the normal subject. However, both patients showed an increase in a-wave amplitude in the dark with maximal amplitude response for dark periods of 50-75 ms. Both patients with CSNB1 also show reduced amplitude inner retinal responses but these were less severely affected than equivalent responses of the AI patients; the a-wave was also slightly reduced in amplitude for P4 but not for P3. A-wave amplitude for these two patients showed minimal change after a brief period of darkness. The ERG response for the CSNB2 patient showed a normal a-wave and clearly defined b-wave but reduced amplitude PhNR and OPs. However, the a-wave increased in amplitude in the dark similar to normal subjects. The a-wave peak was also prolonged in latency in the light for all three patient groups; peak latency in the dark did not change for the AI or CSNB1 patients but became even more prolonged for the CSNB2 patient.
The reduced amplitude a-waves for the AI and one CSNB1 patient raises the question as to whether this is due to cone photoreceptor abnormality or to change to the late post-receptoral component of the a-wave. Therefore we measured the amplitude of the a-wave at 8 ms as well as at response peak. Fig. 4 shows the plots of a-wave amplitude recorded to a red flash presented against a steady background. The amplitude of the a-wave at 8 ms as well as at peak time was significantly smaller than normal for both AI patients confirming a sub-normal cone photoreceptor response. A-wave amplitude at 8 ms was at the lower limit of the normal range for both CSNB1 patients but was normal for the CSNB2 patient.
The peak a-wave amplitudes recorded against a steady background and shown in the right panel of Fig. 4 were re-plotted on a compressed y-axis and are shown in the left panel of Fig. 5 ; the maximal peak amplitude responses recorded after 50-100 ms darkness are shown in the right panel of Fig. 5 . Every normal subject showed a substantial increase in peak a-wave amplitude in the dark; the increase ranged from 150% to 238%. A-wave amplitude increased by 338% and 400% for the AI patients; this relative increase was greater than that seen for any of the normal subjects and peak amplitude in the dark was normal for P1 and at the lower limit of normal for P2. A-wave amplitude for the CSNB2 patient (P5) also increased in the dark by 159%; the relative increase and maximal amplitude in the dark were both within the range of normal values. Conversely, both CSNB1 patients showed minimal increase (145% and 150%) and maximal amplitudes in the dark were also at or below those of the normal volunteers. Fig. 6 shows peak a-wave amplitude plotted against stimulus delay (time in dark after briefly extinguishing the background) for the full range of stimulus delay times studied. Mean amplitudes for the eight normal subjects are shown in the left panel and the responses for each subject were of a similar form with a maximal peak amplitude recorded when the stimulus was delayed by 75 ms or 100 ms. The responses for each patient are plotted separately in the three panels to the right. Responses were measured for stimulus delays extending from 0 ms to 300 ms for all subjects except the CSNB2 patient; for the latter patient measurements were only obtained for stimulus delays extending to 100 ms because of clinic time constraints. The amplitude-response function for both AI patients was comparable with that for the normal subjects. The stimulus-response function for the CSNB2 patient was also similar to normal over the 0-100 ms time period investigated; the peak amplitude measurement for the response recorded against a steady background (plotted as À50 ms on the x-axis) may not be accurate because the form of this response was slightly distorted by eye movement or blink artefact (see also the right panel of Fig. 3) . The stimulus-response function for CSNB1 patient P4 is similar in form to that of normals, but with a much reduced maximal amplitude for a 100 ms stimulus delay. CSNB1 patient P3 does not show a significant, systematic change in amplitude with increasing stimulus delay.
Discussion
We recorded ERGs in patients with confirmed inner retinal disease to specifically investigate the contribution of HBCs or other secondary hyperpolarising neurones to the cone a-wave.
Two patients were diagnosed with autoimmune-like retinopathy (AI) because their unilateral symptoms and ERG abnormality were similar to reported cases of autoimmune-related disease (Audo et al., 2008; Heckenlively et al., 2006) ; there is currently no definitive laboratory test for the non-neoplastic forms of the disease. Clinical ERGs of both patients showed severe abnormality of all dark and light adapted inner retinal responses. Because the d-wave was abnormal, indicating an OFF-pathway defect, we did not expect the cone a-wave to a red flash to increase in the dark but in fact the response of both patients increased substantially after 50-100 ms darkness (see Fig. 3 ). The maximal amplitude in the dark was comparable with that of normal subjects in one patient and only slightly smaller than normal in the other patient (see Fig. 5 ). One factor that may contribute to an explanation for the observed change is that the later part of the a-wave is unmasked when the b-wave is reduced or absent. The observation that the cone a-wave peak is broader and persists longer before being countered by positive polarity signals (Fig. 3) is consistent with this view. We also considered the relative increase in amplitude in the dark because the photoreceptor response (measured at 8 ms) was smaller than normal in one patient. Both patients showed a greater-than-normal increase in amplitude in the dark (330% and 400%) relative to the response recorded when there was a steady background. These results indicate that the a-wave receives a substantial continuing hyperpolarising cell contribution in both patients. If the patients symptoms are indeed caused by autoimmune-related disease, the abnormally low amplitude a-wave at 8 ms as well as at peak in both patients provides new evidence that cone photoreceptors must be affected in some patients with this disease. The abnormal d-waves (OFF-pathway) indicate that secondary hyperpolarising cells must also be affected, contrary to previous evidence that circulating antibodies affect only DBCs (Alexander et al., 1992; Fishman et al., 1996; Lei et al., 2000) . Two factors may account for these discrepancies. Firstly, OFF responses to long-flash stimuli have not been recorded in some studies of autoimmune-related disease so HBC involvement cannot be absolutely excluded. Secondly, clinical and ERG variations are likely to occur given the variety of antigens and complex proteins that may be involved (Adamus, Ren, & Weleber, 2004; Mizener et al., 1997; Peek et al., 1998) .
Abnormal OFF d-waves have been reported previously in larger series of patients with CSNB2, indicating abnormality affecting secondary hyperpolarizing neurons as well as DBCs (Miyake et al., 1987a; Langrova et al., 2002) . Unfortunately the long-flash ERG responses of our patient with CSNB2 were technically too poor to confirm that the OFF d-wave was abnormal but the preserved dark adapted OPs and especially the light adapted ERG responses to a brief flash and to 30 Hz flicker clearly distinguish this form of the disease from CSNB1 (Allen et al., 2003; Bradshaw et al., 2004; Miyake et al., 1987a; Sustar et al., 2008; Tremblay et al., 1995) . Interestingly, his ERG responses were as severely affected as those of our patients with AI retinopathy. Abnormality of the OFF-pathway should reduce or eliminate the hyperpolarising cell contribution to the cone a-wave but again, contrary to expectation, the a-wave changed in form and increased in amplitude in the dark and the maximal amplitude was within the range of normal values (see Figs. 3 and 5). Therefore, our results provide new evidence for continuing hyperpolarising cell function in CSNB2.
Our results in both AI and CSNB2 patients indicate a continuing hyperpolarising cell contribution to the cone a-wave. This input can be from HBCs or/and HCs. Previous studies have considered HBCs the most likely candidate (Bush & Sieving, 1994; Robson et al., 2003) but possible involvement of HCs should not be ignored. Falk and Shiells (Falk & Shiells, 1986) provided direct evidence for a HC contribution by showing that a negative polarity signal remaining after application of APB had a time course similar to that of HCs. It has also been shown that the afterpotential of A-type HCs in rabbit occurs concurrently with the PIII negative component of the ERG over a range of stimulus intensities, implying that the initial potential of HCs may also contribute to the ERG but are obscured by the b-wave (Hanitzsch, Karbaum, & Lichtenberg, 1999) . We cannot speculate further about why the a-wave is unaffected in AI because the antigen involved and their mechanism of action is not known. However, CSNB2 can be diagnosed with confidence and causative mutations are known; this allows us to tentatively propose a possible mechanism underlying our results in CSNB2.
CSNB2 is caused by a mutation of the CACNA1F gene and a number of specific types of mutation have been identified (Boycott et al., 2001; Peloquin, Rehak, Doering, & McRory, 2007) . The way in which these specific mutations affect retinal cell function is not understood at the present time but some recently reported findings suggest a possible mechanism underlying our observed changes to the cone ERG a-wave. The CACNA1F gene encodes the alpha 1 F subunit in the Ca 1.4 voltage dependent calcium channel . Such channels control the release of the transmitter glutamate from photoreceptors to bipolar and horizontal cells. In the nob2 mouse with a mutation in CAC-NA1F the outer plexiform layer is disorganized with ectopic neurites from rod bipolar and horizontal cells and compromised cone pedicles (Chang et al., 2006; Doering et al., 2007) . It has also been shown that the F742C mutation, which also occur in humans with CSNB2 , result in an active Ca-channel but with altered features which enable a greater influx of calcium at any given voltage within the operating range of the photoreceptors. The dynamic range, however, of the photoreceptor is dramatically reduced when compared with physiological conditions. Perhaps very specific changes in the Ca 1.4 voltage dependent calcium channel cause very special changes in hyperpolarising neurons that reduces their response at light OFF but do not impair the response at light ON so that there can be a normal increase in the a-wave after a brief dark adaptation as described here.
Compared with CSNB2, CSNB1 is considered to be a model system for studying exclusively ON-pathway abnormality in humans (Khan et al., 2005; Langrova et al., 2002) . CSNB1 can be caused by mutations in NYX, GRMG6 and TRPM1 genes (Bech-Hansen et al., 2010; Claassen et al., 2010) . The NYX gene is responsible for the expression of the protein Nyctalopin (Bech-Hansen et al., 2000; Pusch et al., 2000) . Nyctalopin is necessary for the expression and function of the TRPM1 channel (Bellone et al., 2008) , a special cation channel gated by the mGluR6-Nyctalopin signalling cascade in ON-bipolar cells (Claassen et al., 2010) . This channel has been found at rod bipolar cells (Gregg et al., 2007) and at cone ONbipolar cells but spares certain types of cone ON-bipolar cells (Gregg et al., 2007; Morgans et al., 2009) . Pharmacological suppression of ON-pathway function in non-human primate has been shown to cause ERG changes that mimic those seen in CSNB patients with the NYX gene mutation (Khan et al., 2005) . Given this strong evidence for selective ON-pathway abnormality we expected that the a-wave would increase in amplitude in the dark in CSNB1 similar to normal subjects. In fact our patients did not show a significant change to a-wave amplitude or waveform to a red flash presented after a short period of darkness compared with responses recorded to the same stimulus on a steady background. This unexpected finding therefore provides evidence that there can be an OFF-pathway defect in CSNB1.
Before speculating on possible mechanisms underlying these awave results it will be useful to briefly summarise what is known about the cellular origin of the cone-driven a-and d-waves; for an authoratative review see Frishman (2006) . The d-wave is the primary response used in clinical ERGs to determin whether or not there is abnormality of the OFF-pathway. It is a positive-going deflection recorded at light offset under photopic conditions and consists of a initial rapid rise to a sharply defined peak followed by a series of smaller oscillations on the descending limb of the response (see normal waveform shown in Fig. 1) ; there is also a later, longer-lasting slow phase which is not normally recorded in its full extent in clinical ERG studies. Pharmacological dissection studies have shown that the initial fast rising phase receives a strong contribution from the depolarising response at light offset of cone HBCs/ HCs (Bush & Sieving, 1994; Ueno et al., 2006) . It also receives a signal of opposite polarity from the hyperpolarising response of DBCs at light offset (Ueno et al., 2006) . There is also a small but significant contribution from inner retinal neurones to the initial rapid phase and the oscillatory components. The cone photoreceptor contributes mainly to the late slow phase rather than the initial rapid phase. The cone a-wave is a negative-going potential recorded at light onset and is truncated by the positive-going b-wave generated by DBCs in the ON-pathway. The initial rapid phase of the a-wave reflects the cone photocurrent. Removal of the b-wave reveals a later, more slowly recovering portion called the later receptor potential which is now considered to reflect the recovery phase of the receptor photoresponse. Pharmacological dissection studies in non-human primate (Bush & Sieving, 1994; Robson et al., 2003) and parametric ERG studies in human (Bradshaw, 2007; Friedburg et al., 2004) have also revealed a later slow post-receptoral signal that is also negative in polarity; this is thought to be generated by hyperpolarising cells post-synaptic to the photoreceptor in the cone OFF-pathway. This signal sums with the cone photocurrent and it is the component which we have investigated with the red flash procedures in our patients. Therefore, the main contributor to the later part of the cone awave is from secondary hyperpolarising neurones.
We may now consider the anomalous a-wave results in our patients with CSNB1. The initial fast part of the d-wave is, as we have seen, the sum of responses of depolarising (ON-pathway) and hyperpolarising (OFF-pathway) neurones. If a defect of the TRPM1 channel severely impairs the function of depolarising neurones, the fast part of the d-wave will be determined to a greater extent by hyperpolarising neurones and so the d-wave should be enlarged. However, the majority of studies, including ours, report normal d-waves in CSNB1 (Langrova et al., 2002; Miyake et al., 1986; Sustar et al., 2008) . This can only happen if the OFF-pathway is impaired to some extent. A larger-than-normal d-wave has been reported in a patient with CSNB1 (Khan et al., 2005) and in a patient with autoimmune-like retinopathy (Fishman et al., 1996) but the incidence of abnormal dwaves cannot be assessed accurately because some studies present results in only a small number of patients and there is often a absence of quantitative d-wave amplitude data. Also, variability in the genetic defects may cause some variability between families with CSNB1. In the future it may be worthwhile to search for TRPM1 channels and possible defects in hyperpolarising neurones and especially in axon terminals of B-type HCs which receive input from rods and establish an intense network in the outer retina (Dowling, 1987; Peichl, Sandmann, & Boycott, 1998; Reitsamer, Pflug, Franz, & Huber, 2006) . A defect in HCs could possibly explain the absence of change in the dark to the post-receptoral part of the cone a-wave in ERGs which do not have a enlarged d-wave. Secondary changes affecting responses of neurones later in the OFF-pathway may also affect the ERG.
In contrast, the later part of the cone a-wave may receive input mainly from secondary hyperpolarising neurones and this difference may underlie the striking dissociation between our d-and a-wave results. So there may be no significant increase in cone awave amplitude in the dark indicating some impairment of secondary hyperpolarising neurones but the d-wave can be of normal size because it is an interference of depolarising and hyperpolarising neurones. That is the case in our patients with CSNB1 and we must conclude that CSNB1 is not a disease that affects only ONpathway function; secondary hyperpolarising neurones may also be impaired. Another possibility is that there can be impairment of secondary hyperpolarizing neurons at light OFF but a substantial reaction at light ON. In the ERG there is then a reduced d-wave but an increase in the a-wave at light ON after a short period of dark adaptation. This is the case in our patients with CSNB2 and AI.
Conclusions
The results in all three groups of patients were contrary to our expectation. Our cone a-wave results provide new evidence for a OFF-pathway defect in CSNB1 and AI retinopathy and for continuing hyperpolarising cell function in CSNB2. In AI and CSNB2 the reduced d-wave indicates impaired secondary hyperpolarising cell function at light OFF but the increase in cone a-wave amplitude in the dark indicates a substantial reaction of hyperpolarising cells at light ON. In our patients with CSNB1 the d-wave was in the normal range and the cone a-wave did not increase in the dark indicating impaired secondary hyperpolarising cells at light ON and OFF. The defect in CSNB1 may be due to abnormality of a specific synaptic mechanism affecting HBCs, but attention should also be given to possible involvement of HCs or to secondary changes affecting neurones later in the OFF-pathway. The strong dissociation between the d-and a-wave results indicates that the dark adapted a-wave after extinguishing a background light can provide important additional information about secondary hyperpolarising cell function.
